<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<GBSeq>

    <GBSeq_locus>NM_172138</GBSeq_locus>
    <GBSeq_length>951</GBSeq_length>
    <GBSeq_strandedness>single</GBSeq_strandedness>
    <GBSeq_moltype>mRNA</GBSeq_moltype>
    <GBSeq_topology>linear</GBSeq_topology>
    <GBSeq_division>PRI</GBSeq_division>
    <GBSeq_update-date>14-DEC-2020</GBSeq_update-date>
    <GBSeq_create-date>04-DEC-2002</GBSeq_create-date>
    <GBSeq_definition>Homo sapiens interferon lambda 2 (IFNL2), mRNA</GBSeq_definition>
    <GBSeq_primary-accession>NM_172138</GBSeq_primary-accession>
    <GBSeq_accession-version>NM_172138.2</GBSeq_accession-version>
    <GBSeq_other-seqids>
      <GBSeqid>ref|NM_172138.2|</GBSeqid>
      <GBSeqid>gi|1720118607</GBSeqid>
    </GBSeq_other-seqids>
    <GBSeq_keywords>
      <GBKeyword>RefSeq</GBKeyword>
      <GBKeyword>MANE Select</GBKeyword>
    </GBSeq_keywords>
    <GBSeq_source>Homo sapiens (human)</GBSeq_source>
    <GBSeq_organism>Homo sapiens</GBSeq_organism>
    <GBSeq_taxonomy>Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo</GBSeq_taxonomy>
    <GBSeq_references>
      <GBReference>
        <GBReference_reference>1</GBReference_reference>
        <GBReference_position>1..951</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Broggi A</GBAuthor>
          <GBAuthor>Ghosh S</GBAuthor>
          <GBAuthor>Sposito B</GBAuthor>
          <GBAuthor>Spreafico R</GBAuthor>
          <GBAuthor>Balzarini F</GBAuthor>
          <GBAuthor>Lo Cascio A</GBAuthor>
          <GBAuthor>Clementi N</GBAuthor>
          <GBAuthor>De Santis M</GBAuthor>
          <GBAuthor>Mancini N</GBAuthor>
          <GBAuthor>Granucci F</GBAuthor>
          <GBAuthor>Zanoni I</GBAuthor>
        </GBReference_authors>
        <GBReference_title>Type III interferons disrupt the lung epithelial barrier upon viral recognition</GBReference_title>
        <GBReference_journal>Science 369 (6504), 706-712 (2020)</GBReference_journal>
        <GBReference_xref>
          <GBXref>
            <GBXref_dbname>doi</GBXref_dbname>
            <GBXref_id>10.1126/science.abc3545</GBXref_id>
          </GBXref>
        </GBReference_xref>
        <GBReference_pubmed>32527925</GBReference_pubmed>
        <GBReference_remark>GeneRIF: Type III interferons disrupt the lung epithelial barrier upon viral recognition.</GBReference_remark>
      </GBReference>
      <GBReference>
        <GBReference_reference>2</GBReference_reference>
        <GBReference_position>1..951</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Luo Q</GBAuthor>
          <GBAuthor>Liu Y</GBAuthor>
          <GBAuthor>Liu S</GBAuthor>
          <GBAuthor>Yin Y</GBAuthor>
          <GBAuthor>Xu B</GBAuthor>
          <GBAuthor>Cao J</GBAuthor>
        </GBReference_authors>
        <GBReference_title>Interleukin 28 is a potential therapeutic target for sepsis</GBReference_title>
        <GBReference_journal>Clin Immunol 205, 29-34 (2019)</GBReference_journal>
        <GBReference_xref>
          <GBXref>
            <GBXref_dbname>doi</GBXref_dbname>
            <GBXref_id>10.1016/j.clim.2019.05.012</GBXref_id>
          </GBXref>
        </GBReference_xref>
        <GBReference_pubmed>31121287</GBReference_pubmed>
        <GBReference_remark>GeneRIF: Serum IL-28A levels were significantly elevated in patients with sepsis compared to healthy controls.</GBReference_remark>
      </GBReference>
      <GBReference>
        <GBReference_reference>3</GBReference_reference>
        <GBReference_position>1..951</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Zakaria ZA</GBAuthor>
          <GBAuthor>Knapp S</GBAuthor>
          <GBAuthor>Hashem M</GBAuthor>
          <GBAuthor>Zaghla H</GBAuthor>
          <GBAuthor>Thursz M</GBAuthor>
          <GBAuthor>Waked I</GBAuthor>
          <GBAuthor>Abdelwahab S</GBAuthor>
        </GBReference_authors>
        <GBReference_title>Interleukin 28A.rs12980602 and interleukin 28B.rs8103142 genotypes could be protective against HCV infection among Egyptians</GBReference_title>
        <GBReference_journal>Immunol Res 67 (1), 123-133 (2019)</GBReference_journal>
        <GBReference_xref>
          <GBXref>
            <GBXref_dbname>doi</GBXref_dbname>
            <GBXref_id>10.1007/s12026-018-9035-2</GBXref_id>
          </GBXref>
        </GBReference_xref>
        <GBReference_pubmed>30402710</GBReference_pubmed>
        <GBReference_remark>GeneRIF: this study shows that interleukin 28A.rs12980602 genotype could be protective against HCV infection among Egyptians</GBReference_remark>
      </GBReference>
      <GBReference>
        <GBReference_reference>4</GBReference_reference>
        <GBReference_position>1..951</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Chaudhary V</GBAuthor>
          <GBAuthor>Zhang S</GBAuthor>
          <GBAuthor>Yuen KS</GBAuthor>
          <GBAuthor>Li C</GBAuthor>
          <GBAuthor>Lui PY</GBAuthor>
          <GBAuthor>Fung SY</GBAuthor>
          <GBAuthor>Wang PH</GBAuthor>
          <GBAuthor>Chan CP</GBAuthor>
          <GBAuthor>Li D</GBAuthor>
          <GBAuthor>Kok KH</GBAuthor>
          <GBAuthor>Liang M</GBAuthor>
          <GBAuthor>Jin DY</GBAuthor>
        </GBReference_authors>
        <GBReference_title>Suppression of type I and type III IFN signalling by NSs protein of severe fever with thrombocytopenia syndrome virus through inhibition of STAT1 phosphorylation and activation</GBReference_title>
        <GBReference_journal>J Gen Virol 96 (11), 3204-3211 (2015)</GBReference_journal>
        <GBReference_xref>
          <GBXref>
            <GBXref_dbname>doi</GBXref_dbname>
            <GBXref_id>10.1099/jgv.0.000280</GBXref_id>
          </GBXref>
        </GBReference_xref>
        <GBReference_pubmed>26353965</GBReference_pubmed>
        <GBReference_remark>GeneRIF: NS of severe fever with thrombocytopenia syndrome virus inhibited the activity of IFN-alpha1, IFN-beta, IFN-lambda1 and IFN-lambda2 through inhibition of STAT1 phosphorylation.</GBReference_remark>
      </GBReference>
      <GBReference>
        <GBReference_reference>5</GBReference_reference>
        <GBReference_position>1..951</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Wack A</GBAuthor>
          <GBAuthor>Terczynska-Dyla E</GBAuthor>
          <GBAuthor>Hartmann R</GBAuthor>
        </GBReference_authors>
        <GBReference_title>Guarding the frontiers: the biology of type III interferons</GBReference_title>
        <GBReference_journal>Nat Immunol 16 (8), 802-809 (2015)</GBReference_journal>
        <GBReference_xref>
          <GBXref>
            <GBXref_dbname>doi</GBXref_dbname>
            <GBXref_id>10.1038/ni.3212</GBXref_id>
          </GBXref>
        </GBReference_xref>
        <GBReference_pubmed>26194286</GBReference_pubmed>
        <GBReference_remark>GeneRIF: Studies indicate that the type III interferons (IFNs) or IFN-lambdas consists of four members: IFN-lambda1 (IL-29), IFN-lambda2 (IL28A), IFN-lambda3 (IL-28B) and IFN-lambda4.
Review article</GBReference_remark>
      </GBReference>
      <GBReference>
        <GBReference_reference>6</GBReference_reference>
        <GBReference_position>1..951</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Brand S</GBAuthor>
          <GBAuthor>Beigel F</GBAuthor>
          <GBAuthor>Olszak T</GBAuthor>
          <GBAuthor>Zitzmann K</GBAuthor>
          <GBAuthor>Eichhorst ST</GBAuthor>
          <GBAuthor>Otte JM</GBAuthor>
          <GBAuthor>Diebold J</GBAuthor>
          <GBAuthor>Diepolder H</GBAuthor>
          <GBAuthor>Adler B</GBAuthor>
          <GBAuthor>Auernhammer CJ</GBAuthor>
          <GBAuthor>Goke B</GBAuthor>
          <GBAuthor>Dambacher J</GBAuthor>
        </GBReference_authors>
        <GBReference_title>IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression</GBReference_title>
        <GBReference_journal>Am J Physiol Gastrointest Liver Physiol 289 (5), G960-G968 (2005)</GBReference_journal>
        <GBReference_xref>
          <GBXref>
            <GBXref_dbname>doi</GBXref_dbname>
            <GBXref_id>10.1152/ajpgi.00126.2005</GBXref_id>
          </GBXref>
        </GBReference_xref>
        <GBReference_pubmed>16051921</GBReference_pubmed>
        <GBReference_remark>GeneRIF: IECs express functional receptors for IFN-lambdas, which mediate antiviral and antiproliferative signals in IECs, suggesting a potential for therapeutic use in certain viral infections and as (antiproliferative) anticancer therapy</GBReference_remark>
      </GBReference>
      <GBReference>
        <GBReference_reference>7</GBReference_reference>
        <GBReference_position>1..951</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Meager A</GBAuthor>
          <GBAuthor>Visvalingam K</GBAuthor>
          <GBAuthor>Dilger P</GBAuthor>
          <GBAuthor>Bryan D</GBAuthor>
          <GBAuthor>Wadhwa M</GBAuthor>
        </GBReference_authors>
        <GBReference_title>Biological activity of interleukins-28 and -29: comparison with type I interferons</GBReference_title>
        <GBReference_journal>Cytokine 31 (2), 109-118 (2005)</GBReference_journal>
        <GBReference_xref>
          <GBXref>
            <GBXref_dbname>doi</GBXref_dbname>
            <GBXref_id>10.1016/j.cyto.2005.04.003</GBXref_id>
          </GBXref>
        </GBReference_xref>
        <GBReference_pubmed>15899585</GBReference_pubmed>
        <GBReference_remark>GeneRIF: we found IL-28A and IL-29 act similarly to IFNs, but are less effective generally and have activity in a more limited range of cell lines</GBReference_remark>
      </GBReference>
      <GBReference>
        <GBReference_reference>8</GBReference_reference>
        <GBReference_position>1..951</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Brand S</GBAuthor>
          <GBAuthor>Zitzmann K</GBAuthor>
          <GBAuthor>Dambacher J</GBAuthor>
          <GBAuthor>Beigel F</GBAuthor>
          <GBAuthor>Olszak T</GBAuthor>
          <GBAuthor>Vlotides G</GBAuthor>
          <GBAuthor>Eichhorst ST</GBAuthor>
          <GBAuthor>Goke B</GBAuthor>
          <GBAuthor>Diepolder H</GBAuthor>
          <GBAuthor>Auernhammer CJ</GBAuthor>
        </GBReference_authors>
        <GBReference_title>SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29</GBReference_title>
        <GBReference_journal>Biochem Biophys Res Commun 331 (2), 543-548 (2005)</GBReference_journal>
        <GBReference_xref>
          <GBXref>
            <GBXref_dbname>doi</GBXref_dbname>
            <GBXref_id>10.1016/j.bbrc.2005.04.004</GBXref_id>
          </GBXref>
        </GBReference_xref>
        <GBReference_pubmed>15850793</GBReference_pubmed>
        <GBReference_remark>GeneRIF: IL-28A and IL-29 induced mRNA expression of the antiviral proteins 2',5'-OAS and MxA was abolished by overexpression of SOCS-1</GBReference_remark>
      </GBReference>
      <GBReference>
        <GBReference_reference>9</GBReference_reference>
        <GBReference_position>1..951</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Kotenko SV</GBAuthor>
          <GBAuthor>Gallagher G</GBAuthor>
          <GBAuthor>Baurin VV</GBAuthor>
          <GBAuthor>Lewis-Antes A</GBAuthor>
          <GBAuthor>Shen M</GBAuthor>
          <GBAuthor>Shah NK</GBAuthor>
          <GBAuthor>Langer JA</GBAuthor>
          <GBAuthor>Sheikh F</GBAuthor>
          <GBAuthor>Dickensheets H</GBAuthor>
          <GBAuthor>Donnelly RP</GBAuthor>
        </GBReference_authors>
        <GBReference_title>IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex</GBReference_title>
        <GBReference_journal>Nat Immunol 4 (1), 69-77 (2003)</GBReference_journal>
        <GBReference_xref>
          <GBXref>
            <GBXref_dbname>doi</GBXref_dbname>
            <GBXref_id>10.1038/ni875</GBXref_id>
          </GBXref>
        </GBReference_xref>
        <GBReference_pubmed>12483210</GBReference_pubmed>
        <GBReference_remark>GeneRIF: closely positioned genes on human chromosome 19 encode distinct but paralogous proteins, which we designate interferon-lambda1 (IFN-lambda1), IFN-lambda2 and IFN-lambda3</GBReference_remark>
      </GBReference>
      <GBReference>
        <GBReference_reference>10</GBReference_reference>
        <GBReference_position>1..951</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Sheppard P</GBAuthor>
          <GBAuthor>Kindsvogel W</GBAuthor>
          <GBAuthor>Xu W</GBAuthor>
          <GBAuthor>Henderson K</GBAuthor>
          <GBAuthor>Schlutsmeyer S</GBAuthor>
          <GBAuthor>Whitmore TE</GBAuthor>
          <GBAuthor>Kuestner R</GBAuthor>
          <GBAuthor>Garrigues U</GBAuthor>
          <GBAuthor>Birks C</GBAuthor>
          <GBAuthor>Roraback J</GBAuthor>
          <GBAuthor>Ostrander C</GBAuthor>
          <GBAuthor>Dong D</GBAuthor>
          <GBAuthor>Shin J</GBAuthor>
          <GBAuthor>Presnell S</GBAuthor>
          <GBAuthor>Fox B</GBAuthor>
          <GBAuthor>Haldeman B</GBAuthor>
          <GBAuthor>Cooper E</GBAuthor>
          <GBAuthor>Taft D</GBAuthor>
          <GBAuthor>Gilbert T</GBAuthor>
          <GBAuthor>Grant FJ</GBAuthor>
          <GBAuthor>Tackett M</GBAuthor>
          <GBAuthor>Krivan W</GBAuthor>
          <GBAuthor>McKnight G</GBAuthor>
          <GBAuthor>Clegg C</GBAuthor>
          <GBAuthor>Foster D</GBAuthor>
          <GBAuthor>Klucher KM</GBAuthor>
        </GBReference_authors>
        <GBReference_title>IL-28, IL-29 and their class II cytokine receptor IL-28R</GBReference_title>
        <GBReference_journal>Nat Immunol 4 (1), 63-68 (2003)</GBReference_journal>
        <GBReference_xref>
          <GBXref>
            <GBXref_dbname>doi</GBXref_dbname>
            <GBXref_id>10.1038/ni873</GBXref_id>
          </GBXref>
        </GBReference_xref>
        <GBReference_pubmed>12469119</GBReference_pubmed>
        <GBReference_remark>GeneRIF: identified from the human genomic sequence a family of three cytokines, designated interleukin 28A (IL-28A), IL-28B and IL-29, that are distantly related to type I interferons (IFNs) and the IL-10 family</GBReference_remark>
      </GBReference>
    </GBSeq_references>
    <GBSeq_comment>VALIDATED REFSEQ: This record has undergone validation or preliminary review. The reference sequence was derived from AC011445.6, AY129148.1 and AA774195.1.; On Aug 7, 2019 this sequence version replaced NM_172138.1.; ~Summary: This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28B (IL28B), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA). [provided by RefSeq, Jul 2008].; ~Sequence Note: This RefSeq record was created from transcript and genomic sequence data to make the sequence consistent with the reference genome assembly. The genomic coordinates used for the transcript record were based on transcript alignments.; ~Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications.; ; ##Evidence-Data-START## ; Transcript exon combination :: DQ126337.1, AY129148.1 [ECO:0000332] ; ##Evidence-Data-END##; ; ##RefSeq-Attributes-START## ; MANE Ensembl match :: ENST00000331982.6/ ENSP00000333639.5 ; RefSeq Select criteria :: based on single protein-coding transcript ; ##RefSeq-Attributes-END##</GBSeq_comment>
    <GBSeq_primary>REFSEQ_SPAN         PRIMARY_IDENTIFIER PRIMARY_SPAN        COMP~1-121               AC011445.6         49498-49618~122-855             AY129148.1         1-734~856-951             AA774195.1         169-264</GBSeq_primary>
    <GBSeq_feature-table>
      <GBFeature>
        <GBFeature_key>source</GBFeature_key>
        <GBFeature_location>1..951</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>1</GBInterval_from>
            <GBInterval_to>951</GBInterval_to>
            <GBInterval_accession>NM_172138.2</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>organism</GBQualifier_name>
            <GBQualifier_value>Homo sapiens</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>mol_type</GBQualifier_name>
            <GBQualifier_value>mRNA</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>taxon:9606</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>chromosome</GBQualifier_name>
            <GBQualifier_value>19</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>map</GBQualifier_name>
            <GBQualifier_value>19q13.2</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
      <GBFeature>
        <GBFeature_key>gene</GBFeature_key>
        <GBFeature_location>1..951</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>1</GBInterval_from>
            <GBInterval_to>951</GBInterval_to>
            <GBInterval_accession>NM_172138.2</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>gene</GBQualifier_name>
            <GBQualifier_value>IFNL2</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>gene_synonym</GBQualifier_name>
            <GBQualifier_value>IFNL2a; IFNL3a; IL-28A; IL28A</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>note</GBQualifier_name>
            <GBQualifier_value>interferon lambda 2</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>GeneID:282616</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>HGNC:HGNC:18364</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>MIM:607401</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
      <GBFeature>
        <GBFeature_key>exon</GBFeature_key>
        <GBFeature_location>1..183</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>1</GBInterval_from>
            <GBInterval_to>183</GBInterval_to>
            <GBInterval_accession>NM_172138.2</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>gene</GBQualifier_name>
            <GBQualifier_value>IFNL2</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>gene_synonym</GBQualifier_name>
            <GBQualifier_value>IFNL2a; IFNL3a; IL-28A; IL28A</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>inference</GBQualifier_name>
            <GBQualifier_value>alignment:Splign:2.1.0</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
      <GBFeature>
        <GBFeature_key>misc_feature</GBFeature_key>
        <GBFeature_location>126..128</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>126</GBInterval_from>
            <GBInterval_to>128</GBInterval_to>
            <GBInterval_accession>NM_172138.2</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>gene</GBQualifier_name>
            <GBQualifier_value>IFNL2</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>gene_synonym</GBQualifier_name>
            <GBQualifier_value>IFNL2a; IFNL3a; IL-28A; IL28A</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>note</GBQualifier_name>
            <GBQualifier_value>upstream in-frame stop codon</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
      <GBFeature>
        <GBFeature_key>CDS</GBFeature_key>
        <GBFeature_location>174..776</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>174</GBInterval_from>
            <GBInterval_to>776</GBInterval_to>
            <GBInterval_accession>NM_172138.2</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>gene</GBQualifier_name>
            <GBQualifier_value>IFNL2</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>gene_synonym</GBQualifier_name>
            <GBQualifier_value>IFNL2a; IFNL3a; IL-28A; IL28A</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>note</GBQualifier_name>
            <GBQualifier_value>interleukin 28A (interferon, lambda 2); IFN-lambda-2; cytokine Zcyto20; interleukin-28A</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>codon_start</GBQualifier_name>
            <GBQualifier_value>1</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>transl_table</GBQualifier_name>
            <GBQualifier_value>1</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>product</GBQualifier_name>
            <GBQualifier_value>interferon lambda-2 precursor</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>protein_id</GBQualifier_name>
            <GBQualifier_value>NP_742150.1</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>CCDS:CCDS42567.1</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>GeneID:282616</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>HGNC:HGNC:18364</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>MIM:607401</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>translation</GBQualifier_name>
            <GBQualifier_value>MKLDMTGDCTPVLVLMAAVLTVTGAVPVARLHGALPDARGCHIAQFKSLSPQELQAFKRAKDALEESLLLKDCRCHSRLFPRTWDLRQLQVRERPMALEAELALTLKVLEATADTDPALVDVLDQPLHTLHHILSQFRACIQPQPTAGPRTRGRLHHWLYRLQEAPKKESPGCLEASVTFNLFRLLTRDLNCVASGDLCV</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
      <GBFeature>
        <GBFeature_key>sig_peptide</GBFeature_key>
        <GBFeature_location>174..248</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>174</GBInterval_from>
            <GBInterval_to>248</GBInterval_to>
            <GBInterval_accession>NM_172138.2</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>gene</GBQualifier_name>
            <GBQualifier_value>IFNL2</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>gene_synonym</GBQualifier_name>
            <GBQualifier_value>IFNL2a; IFNL3a; IL-28A; IL28A</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>note</GBQualifier_name>
            <GBQualifier_value>/evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (Q8IZJ0.1)</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>peptide</GBQualifier_name>
            <GBQualifier_value>MKLDMTGDCTPVLVLMAAVLTVTGA</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
      <GBFeature>
        <GBFeature_key>exon</GBFeature_key>
        <GBFeature_location>184..365</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>184</GBInterval_from>
            <GBInterval_to>365</GBInterval_to>
            <GBInterval_accession>NM_172138.2</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>gene</GBQualifier_name>
            <GBQualifier_value>IFNL2</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>gene_synonym</GBQualifier_name>
            <GBQualifier_value>IFNL2a; IFNL3a; IL-28A; IL28A</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>inference</GBQualifier_name>
            <GBQualifier_value>alignment:Splign:2.1.0</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
      <GBFeature>
        <GBFeature_key>exon</GBFeature_key>
        <GBFeature_location>366..443</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>366</GBInterval_from>
            <GBInterval_to>443</GBInterval_to>
            <GBInterval_accession>NM_172138.2</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>gene</GBQualifier_name>
            <GBQualifier_value>IFNL2</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>gene_synonym</GBQualifier_name>
            <GBQualifier_value>IFNL2a; IFNL3a; IL-28A; IL28A</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>inference</GBQualifier_name>
            <GBQualifier_value>alignment:Splign:2.1.0</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
      <GBFeature>
        <GBFeature_key>exon</GBFeature_key>
        <GBFeature_location>444..593</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>444</GBInterval_from>
            <GBInterval_to>593</GBInterval_to>
            <GBInterval_accession>NM_172138.2</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>gene</GBQualifier_name>
            <GBQualifier_value>IFNL2</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>gene_synonym</GBQualifier_name>
            <GBQualifier_value>IFNL2a; IFNL3a; IL-28A; IL28A</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>inference</GBQualifier_name>
            <GBQualifier_value>alignment:Splign:2.1.0</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
      <GBFeature>
        <GBFeature_key>exon</GBFeature_key>
        <GBFeature_location>594..677</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>594</GBInterval_from>
            <GBInterval_to>677</GBInterval_to>
            <GBInterval_accession>NM_172138.2</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>gene</GBQualifier_name>
            <GBQualifier_value>IFNL2</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>gene_synonym</GBQualifier_name>
            <GBQualifier_value>IFNL2a; IFNL3a; IL-28A; IL28A</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>inference</GBQualifier_name>
            <GBQualifier_value>alignment:Splign:2.1.0</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
      <GBFeature>
        <GBFeature_key>exon</GBFeature_key>
        <GBFeature_location>678..951</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>678</GBInterval_from>
            <GBInterval_to>951</GBInterval_to>
            <GBInterval_accession>NM_172138.2</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>gene</GBQualifier_name>
            <GBQualifier_value>IFNL2</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>gene_synonym</GBQualifier_name>
            <GBQualifier_value>IFNL2a; IFNL3a; IL-28A; IL28A</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>inference</GBQualifier_name>
            <GBQualifier_value>alignment:Splign:2.1.0</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
      <GBFeature>
        <GBFeature_key>regulatory</GBFeature_key>
        <GBFeature_location>932..937</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>932</GBInterval_from>
            <GBInterval_to>937</GBInterval_to>
            <GBInterval_accession>NM_172138.2</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>regulatory_class</GBQualifier_name>
            <GBQualifier_value>polyA_signal_sequence</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>gene</GBQualifier_name>
            <GBQualifier_value>IFNL2</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>gene_synonym</GBQualifier_name>
            <GBQualifier_value>IFNL2a; IFNL3a; IL-28A; IL28A</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>note</GBQualifier_name>
            <GBQualifier_value>hexamer: AATAAA</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
      <GBFeature>
        <GBFeature_key>polyA_site</GBFeature_key>
        <GBFeature_location>951</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_point>951</GBInterval_point>
            <GBInterval_accession>NM_172138.2</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>gene</GBQualifier_name>
            <GBQualifier_value>IFNL2</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>gene_synonym</GBQualifier_name>
            <GBQualifier_value>IFNL2a; IFNL3a; IL-28A; IL28A</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>note</GBQualifier_name>
            <GBQualifier_value>major polyA site</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
    </GBSeq_feature-table>
    <GBSeq_sequence>aggaattacatcccagacagagctcaaaactgacagaaagagtcaaagccaggacacagtctgagatccagaagaggggactgaaaagaacagagactccagacaagacccaaacagaccctgggtgacagcctcagagtgtttcttctgctgacaaagaccagagatcaggaatgaaactagacatgactggggactgcacgccagtgctggtgctgatggccgcagtgctgaccgtgactggagcagttcctgtcgccaggctccacggggctctcccggatgcaaggggctgccacatagcccagttcaagtccctgtctccacaggagctgcaggcctttaagagggccaaagatgccttagaagagtcgcttctgctgaaggactgcaggtgccactcccgcctcttccccaggacctgggacctgaggcagctgcaggtgagggagcgccccatggctttggaggctgagctggccctgacgctgaaggttctggaggccaccgctgacactgacccagccctggtggacgtcttggaccagccccttcacaccctgcaccatatcctctcccagttccgggcctgtatccagcctcagcccacggcagggcccaggacccggggccgcctccaccattggctgtaccggctccaggaggccccaaaaaaggagtcccctggctgcctcgaggcctctgtcaccttcaacctcttccgcctcctcacgcgagacctgaattgtgttgccagtggggacctgtgtgtctgaccctcccaccagtcatgcaacctgagattttatttataaattagccacttgtcttaatttattgccacccagtcgctatttatgtatttgtgtgtgtaaatccaactcacctccaggaaaatgtttatttttctactttttataacccttgttgaaataaacaaaggaaaagaca</GBSeq_sequence>
  </GBSeq>
